Malaysia Medical Device Registration

Unlock the Malaysian market with expert regulatory guidance, quality oversight, and an independent local authorized representative, with Cisema.

We help foreign manufacturers of medical devices and IVDs in Malaysia navigate the full registration process, meet requirements set by the Medical Device Authority (MDA), and maintain product quality across the entire supply chain. As your fully licensed authorized representative, we manage your device registration in Malaysia from initial strategy to post-market monitoring.

With a licensed local entity in Penang and a team deeply familiar with the Medical Device Act 2012, Cisema acts as your Local Authorized Representative, Marketing Authorization Holder, and embedded regulatory partner. We provide full support for technical documentation, regulatory planning, and quality assurance, helping you access not just Malaysia but broader Southeast Asia.

Quality Control for Medical Devices in Malaysia
Medical Device Registration in Malaysia
Malaysia Local Authorized Representative

Malaysia is emerging as a strategic hub for medical and healthcare technologies in the region. Whether you're looking to register a product, validate imported components, or ensure regulatory conformity before distribution, Cisema’s integrated services give you clarity, speed, and control.

From risk classification and dossier preparation to inspections and post-market monitoring, we simplify your path to market entry. We also assist with meeting quality management system expectations, planning for reference country approval, and ensuring full conformity assessment readiness.

Malaysia Medical Device Registration Services

Cisema’s regulatory team manages your entire registration application with the Medical Device Authority MDA, aligning with local requirements and ASEAN standards.

Regulatory Strategy & Classification

Determine how your medical devices & IVDs are classified under Malaysia’s four classes (A to D)
Conduct product classification and risk-level analysis
Plan the ideal registration pathway for your product type

Technical Documentation & Dossier Preparation

Prepare and localize all documents according to ASEAN CSDT
Translate and adapt instructions for use, labels, and packaging
Ensure your device or IVD meets local performance requirements and complies with the MDA's conformity assessment body expectations

Registration Application & Submission

File submissions via the MeDC@St 2.0 system
Act as your regulatory contact and submit responses to authority queries
Support for application fee, registration fee, and MeDC@St access setup

Post-Approval Services

Manage renewals, modifications, and license updates before expiry date
Help with reclassifications or changes in risk level
Support with incident monitoring and post-market obligations

Optional Add-Ons

Applications under expedited or Special Access Pathway where applicable
Simultaneous or phased multi-country ASEAN registration support
Strategic advice on license renewal, reclassification, or changes post-approval.

Local Authorized Representative (LAR) Services in Malaysia

All foreign manufacturers of medical devices and IVDs in Malaysia must appoint a Local Authorized Representative (LAR) to serve as the legal license holder and regulatory liaison throughout the registration process with the Medical Device Authority MDA. Cisema fulfills this role with full compliance, transparency, and strategic flexibility.

Legal License Holder

Officially represent your company before the Malaysian Medical Device Authority
Maintain product listings in MeDC@St 2.0
Handle registration renewals, scope changes, and change notification filings

Distributor LoAs

Issue Letters of Authorization (LoAs) to your selected distributors and importers
Avoid distributor lock-in by changing partners without re-registering your device

Regulatory Compliance

Monitor updates from the Medical Device Authority (MDA)
Submit classification changes, post-market modifications, and renewals ahead of the expiry date
Keep your device registration in Malaysia fully compliant across its lifecycle

Post-Market Vigilance

Handle adverse event reporting and regulatory notifications
Coordinate Field Safety Corrective Actions (FSCAs), recalls, and corrective submissions
Support full conformity with Malaysian market safety requirements

Conformity Assessment Bodies Collaboration

Provide documentation for audits or inspections by a registered CAB
Assist with conformity assessment requirements tied to device classification and risk

Regulatory Strategy

Offer regulatory insights at no extra cost for LAR clients
Advise on ASEAN rollout strategies and expansion across Asia Pacific
Guide your implementation of a compliant quality management system

Global Communication

Provide multilingual support in English, Mandarin, German, and more
Align with your commercial, regulatory, and quality teams across time zones.

Quality Control Inspection Services for Medical Devices in Malaysia

Cisema also offers inspection services tailored to healthcare products including medical devices and IVDs in Malaysia, helping ensure regulatory conformity and reduce risk to protect patient safety. Whether importing finished goods or sourcing components for assembly, we help you meet MDA and international expectations for quality.

Incoming Goods Inspections

Visual inspection and verification of packaging, labeling, and transit damage
Documentation check: invoices, certificates, and conformity documents
Confirmation that products meet health Malaysia and international regulations

In-Process Quality Monitoring

Inspections during local manufacturing or repackaging
Lot traceability, batch consistency, and hygiene audits
SOP implementation and in-line process control

Final Product Release Inspections

AQL sampling, defect categorization, and performance checks
Label and IFU reviews for MDA conformity
Product readiness evaluation before distribution

Special Inspection Projects

Audit preparation for conformity assessment, ISO, or MDSAP
Registered CAB collaboration for custom compliance audits
Recall sample checks, reworked goods assessment, and serial number validation

Transparent Reporting

Inspection reports with photos, pass/fail status, and root cause summaries
Flexible service levels: Bronze, Silver, Gold.

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Role of a China Agent

Discover our other Medical Device Consulting Services

China

Hong Kong SAR

Singapore

Vietnam

Taiwan

Philippines

Indonesia

Thailand

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

Cisema supported Inox Torres Group in successfully renewing its China SELO license for Level A2 pressure vessels through expert audit preparation and regulatory guidance.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More

Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices

Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements

April 17, 2026
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Two professionals in an office review documentation for a HealthScreen glucose monitor while examining a computer display showing a product label with model number, barcode, and QR code. One person points to the code on the screen as the other reads.

Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications

Malaysia’s NPRA introduces reliance and priority review pathways for additional indications of registered innovator drugs.

April 17, 2026
Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications

Malaysia Withdraws MDA Guidance on Importation of Medical Devices for Personal Use

Malaysia’s MDA withdraws personal use medical device importation Guidance Document, directing stakeholders to updated exemption requirements.

April 17, 2026
Malaysia Withdraws MDA Guidance on Importation of Medical Devices for Personal Use

Malaysia Mandates Testing for Diethylene Glycol (DEG) and Ethylene Glycol (EG) in High-Risk Oral Liquid Products

Malaysia’s NPRA mandates DEG and EG testing for high-risk oral liquid products , with mandatory compliance starting April 1, 2027.

April 17, 2026
Malaysia Mandates Testing for Diethylene Glycol (DEG) and Ethylene Glycol (EG) in High-Risk Oral Liquid Products

Malaysia Mandates GCP 5th Edition for Clinical Trials Under New NPRA Directive

Malaysia’s NPRA issues Directive No. 7 of 2026 mandating the Malaysian Guideline for GCP 5th Edition for clinical trials.

April 17, 2026
Malaysia Mandates GCP 5th Edition for Clinical Trials Under New NPRA Directive

Malaysia–Thailand Regulatory Reliance Pilot Opens Faster Pathway for Medical Device Approvals

Malaysia’s MDA and Thailand’s FDA launch a medical device reliance pilot to accelerate market access for Class B–D devices.

April 17, 2026
Malaysia–Thailand Regulatory Reliance Pilot Opens Faster Pathway for Medical Device Approvals
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device or IVD in Malaysia.

Request Proposal